Home/Filings/4/0001214659-22-003919
4//SEC Filing

Kilcoyne Adrian 4

Accession 0001214659-22-003919

CIK 0001293310other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 4:37 PM ET

Size

11.0 KB

Accession

0001214659-22-003919

Insider Transaction Report

Form 4
Period: 2022-03-08
Kilcoyne Adrian
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2022-03-08$2.53/sh+7,000$17,7107,000 total
  • Purchase

    Common Stock

    2022-03-09$2.78/sh+5,000$13,90012,000 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.52 to $2.53, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.75 to $2.80, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

HUMANIGEN, INC

CIK 0001293310

Entity typeother

Related Parties

1
  • filerCIK 0001857963

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:37 PM ET
Size
11.0 KB